StockData

Translational Development Acquisition Corp. (TDAC) stock

TDACNasdaqBlank ChecksFiscal year ends December 31Also trades as TDACU, TDACW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$10.87+0.01 (+0.09%)

Close on Nov 17, 2026Market cap $209.89MP/E –Yield –

Translational Development Acquisition total assets

Total assets on the balance sheet at the end of each period.

Translational Development Acquisition's total assets was $157.37M at Jun 30, 2026. For fiscal 2025 it was $181.70M, up 3.8% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$181.70M+3.8%
FY2024Dec 31, 2024$175.00M+8659008.3%
FY2023Dec 31, 2023$2.02K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$157.37M-11.7%
Q1 FY2026Mar 31, 2026$183.35M+3.8%
Q4 FY2025Dec 31, 2025$181.70M+3.8%
Q3 FY2025Sep 30, 2025$179.98M+8905375.5%
Q2 FY2025Jun 30, 2025$178.18M–
Q1 FY2025Mar 31, 2025$176.60M–
Q4 FY2024Dec 31, 2024$175.00M–
Q4 FY2023Dec 31, 2023$2.02K–

More Translational Development Acquisition figures

See a number that looks wrong?